Endoscopic Submucosal Dissection of Gastric Superficial Lesions: Predictors for Time of Procedure in a Portuguese Center  by Ribeiro-Mourão, Francisco et al.
GO
E
S
i
F
P
a
b
c
R
A
h
2
CE Port J Gastroenterol. 2015;22(2):52--60
www.elsevier.pt/ge
RIGINAL ARTICLE
ndoscopic  Submucosal  Dissection  of Gastric
uperﬁcial Lesions:  Predictors  for Time  of Procedure
n a  Portuguese  Center
rancisco Ribeiro-Mourãoa,∗, Nuno Velosoa,b, Mário Dinis-Ribeiroa,b, Pedro
imentel-Nunesa,b,c
CINTESIS/CIDES,  Faculdade  de  Medicina  do  Porto,  Porto,  Portugal
Gastroenterology  Department,  Instituto  Português  de  Oncologia  do  Porto  Francisco  Gentil,  Porto,  Portugal
Physiology  Department,  Faculdade  de  Medicina  do  Porto,  Porto,  Portugal
eceived  11  October  2014;  accepted  26  January  2015
vailable  online  20  March  2015
KEYWORDS
Dissection;
Endoscopy,
Gastrointestinal;
Operative  Time;
Stomach  Neoplasms
Abstract
Background:  Endoscopic  submucosal  dissection  (ESD),  an  endoscopic  technique  used  for  treat-
ment of  gastric  superﬁcial  lesions,  has  been  gaining  importance  on  western  countries.
Procedural  times  have  an  impact  on  various  outcomes.
Aim:  To  deﬁne  which  factors  from  patients,  lesions  and  procedure  can  predict  longer  procedural
times.
Methods: In  a  cohort  of  127  lesions  resected  by  ESD  with  IT-knife,  after  using  needle-knife
for submucosal  layer  access,  by  experienced  gastroenterologists,  characteristics  from  the
patient (age,  gender,  presence  of  co-morbidities,  usage  and  suspension  of  anti-platelet  drugs
and general  physical  condition),  lesion  (size,  histopathological  diagnosis  at  biopsy,  location,
macroscopic  type  and  submucosal  invasion)  and  procedure  (adverse  events)  were  retrospec-
tively analyzed  for  its  impact  on  time  of  procedure.  Univariate  and  multivariate  analysis  were
performed.
Results:  Lesions  larger  than  20  mm  (p  <  0.001),  on  the  upper  third  of  the  stomach  (p  =  0.035)
and with  an  ASA  score  of  3  (p  =  0.031)  were  considered  inﬂuential  factors  for  a  longer  procedure
time and  speciﬁcally  for  a  time  of  procedure  longer  than  90  min.  Existence  of  intra-procedure
adverse events  was  also  a  predictor  for  a  procedure  time  >90  min.  Lesion’s  size  >20  mm  and
 were  independently  associated  with  a  procedure  time  longer  than
--10.50]  and  OR  18.26  [95%CI  2.02--164.78],  respectively).location in  the  upper  third
90 min  (OR  4.91  [95%CI  2.29∗ Corresponding author.
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Conclusion:  The  time  of  procedure  of  ESD  for  gastric  superﬁcial  lesions  is  inﬂuenced  by  size
of lesion  (>20  mm)  and  location  (upper  third  of  stomach),  which  predict  a  time  longer  than
90 min.  This  can  be  useful  for  better  management  of  workﬂow,  operation,  training  of  teams
and anesthesic  procedures.
©  2014  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Dissecc¸ão  Endoscópica  da  Submucosa  de  Lesões  Superﬁciais  Gástricas:  Preditores  do
Tempo  de  Procedimento  num  Centro  Português
Resumo
Introduc¸ão:  A  Dissec¸ão  Endoscópica  de  Submucosa  (ESD),  uma  técnica  utilizada  para  o  trata-
mento de  lesões  gástricas  superﬁciais,  tem  ganho  importância  no  Ocidente.  O  tempo  de
procedimento  tem  impacto  nos  outcomes.
Objetivo:  Deﬁnir  os  fatores  do  paciente,  da  lesão  e  do  procedimento  que  predizem  um  tempo
de procedimento  prolongado.
Métodos:  Numa  coorte  de  127  lesões  removidas  por  ESD  com  IT-knife, após  utilizac¸ão  de  needle-
knife para  acesso  à  camada  submucosa,  por  gastrenterologistas  experientes  foram  analisadas,
retrospetivamente,  características  dos  pacientes  (idade,  género,  presenc¸a  de  co-morbilidades,
toma/suspensão  de  agentes  anti-plaquetários  e  condic¸ão  física),  das  lesões  (tamanho,  diagnós-
tico histopatológico  na  biopsia,  localizac¸ão,  características  macroscópicas  e  invasão  submucosa)
e do  procedimento  (complicac¸ões).  Foi  realizada  análise  univariada  e  multivariada.
Resultados:  Lesões  >20  mm  (p<0,001),  no  terc¸o superior  do  estômago  (p=0,035)  e  em  pacientes
com um  índice  ASA  3  (p=0,031)  foram  considerados  como  fatores  com  inﬂuência  para  tempo
de procedimento  prolongado  e,  especiﬁcamente,  para  um  tempo  de  procedimento  superior  a
90 minutos.  A  existência  de  complicac¸ões  intra-procedimento  também  foi  considerada  como
um preditor  para  um  tempo  >90  minutos.  Uma  lesão  >20  mm  e  a  localizac¸ão  no  terc¸o supe-
rior estiveram  associadas  independentemente  com  um  tempo  de  procedimento  superior  a  90
minutos (OR  4.91  [IC  95%  2.29-10.50]  e  OR  18.26  [IC  95%  2.02-164.78],  respetivamente)
Conclusões:  O  tempo  de  procedimento  da  ESD  para  lesões  superﬁciais  gástricas  é  inﬂuenciado
pelo tamanho  e  localizac¸ão  das  lesões,  sendo  preditores  de  um  tempo  de  procedimento  supe-
rior a  90  minutos.  Estes  dados  são  importantes  para  melhor  gestão  da  dinâmica  de  trabalho,
procedimento,  formac¸ão  das  equipas  e  procedimentos  anestésicos.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.
Este é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
o
T
i
w
a
w
r
p
v
21. Introduction and background
Endoscopic  submucosal  dissection  (ESD)  is  an  endoscopic
technique  used  for  treatment  of  gastric  superﬁcial  lesions.1
It  has  been  widely  used  in  countries  such  as  Korea  and
Japan,  but  its  use  only  widespread  in  the  Western  countries
in  the  last  decade.2 Although  having  successful  results,3--5
ESD  requires  a  high  level  of  expertise  in  order  to  reach  the
desired  outcomes.6--7
Speciﬁcally,  longer  procedural  times  are  related  to  a
higher  level  of  adverse  events8 such  as  delayed  bleeding,9
perforation,10--11 post-operative  pneumonia11--13 and  other
clinical  adverse  events  related  to  premedication  and  a
heavy  workload  for  patients.7 Moreover,  previous  ret-
rospective  studies  have  shown  that  time  of  procedure
can  be  inﬂuenced  by  different  factors  such  as  existence
of  ﬁbrosis,14--15 presence  of  ulceration,7,15--17 area  of  the
resected  specimen,7,16--19 location  on  the  upper  portion
2
O
uf  the  stomach,7,16--19 adhesion19 and  presence  of  a  scar.7
herefore,  it  is  essential  to  take  these  factors  into  account
n  the  pre-operatory  period,  since  they  can  inﬂuence  the
orkﬂow  for  ESD  such  as  allocation  of  type  of  rooms  and
nesthesic  procedures,  and  level  of  training  of  teams.11
Considering  this  impact  of  procedure  time,  the  present
ork  aims  at  addressing  the  procedure  time  of  ESD  for
emoval  of  superﬁcial  gastric  lesions  and  to  deﬁne  which
atients’  characteristics,  lesions’  features  and  procedure
ariables  may  be  predictors  of  longer  procedural  times.
.  Materials and methods.1.  Type  of  study  and  selection  of  patients
ur  study  reports  a  retrospective  cohort  of  162  consec-
tively  patients  (with  195  gastric  neoplastic  lesions)  that
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ere  referred  to  the  Portuguese  Institute  of  Oncology  --
orto  (IPO)  from  March  2003  to  April  2013  for  assessment
nd  treatment  of  gastric  superﬁcial  neoplasias.  This  study
as  conducted  in  accordance  with  the  ethical  principles  of
he  Declaration  of  Helsinki,  in  compliance  with  good  clinical
ractice.
All  patients  were  referred  for  endoscopic  treatment  after
 multidisciplinary  oncology  group  decision  and  full  medi-
al  and  anesthesiology  evaluation.  Both  oral  and  written
nformed  consent  was  given  by  patients.  All  the  endo-
copic  procedures  performed  on  IPO  during  this  period  were
creened  by  their  report  on  the  institute  database,  followed
y  analysis  of  the  clinical  record  of  the  patient.
Results  related  with  other  outcomes  regarding  the  long-
erm  follow-up  of  this  cohort,  that  are  outside  the  aim  of
his  analysis,  were  already  published  by  our  team.20Flowchart  followed  for  patients’  selection  can  be  found
n  Fig.  1.  For  the  purpose  of  this  study,  only  cases  treated
y  ESD,  without  ulcerative  ﬁndings  on  the  lesion,  and  tech-
ically  performed  with  IT-knife  were  selected.  Fifty-three
P
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Lesions referred for endoscopic assessment (n=195)
Procedural time available?
Treatment by ESD?
N
N
N
Yes
Yes
Yes
Selected lesions (n=127)
Only IT-knife used?
Figure  1  Flowchart  for  patieF.  Ribeiro-Mourão  et  al.
rocedures  were  excluded  because  they  were  treated  by
ndoscopic  mucosal  resection  (EMRc).  Of  the  ESD  proce-
ures,  one  was  excluded  because  Flex-knife  was  used  along
ith  IT  knife,  six  were  excluded  because  diathermic  loop
as  used  along  with  IT-knife  and  two  were  excluded  because
e  used  a  hybrid  technique  (ESD  followed  by  EMRc).  Six
rocedures  were  excluded  due  to  incomplete  information
egarding  time  of  procedure.
.2.  Description  of  endoscopic  resection
echniques
wo  operators  effectuated  the  endoscopic  procedures  (MDR
nd  PPN).  MDR  received  training  in  Japan  and  in  live  animal
ourses  before  introducing  the  technique  in  the  Hospital.
PN  had  animal  training  and  then  gradually  begun  the  endo-
copic  procedures  under  MDR  supervision  in  2010.21--22
Lateral  margins  of  each  lesion  were  always  determined
y  chromoendoscopy  with  indigo  carmine  1%23--25 or  with
n=6 excluded
n=53 excluded
o
o
o n=1 excluded (Flex knife + IT knife)
n=6 excluded (Diathermic loop + IT knife)
n=2 excluded (ESD followed by EMRc)
nts  inclusion  in  the  study.
ons  
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virtual  chromoendoscopy  using  HR-NBI  (applying  Pimentel-
Nunes  et  al.  classiﬁcation  for  delimitation  of  lesions26)  and
small  marks  were  made  2--5  mm  from  the  edges  of  the  lesion
using  needle-knife  coagulation.  The  technique  of  endoscopic
submucosal  dissection  (ESD)  was  initiated  after  the  sub-
mucosal  injection  of  the  lesion  with  an  epinephrine  and
saline  solution  (1:100,000)  and  a  few  drops  of  methylene
blue.  After  that  to  obtain  access  to  the  submucosal  layer
3--4  small  mucosal  incisions  using  needle-knife  were  made.
Then,  an  IT-knife  (Olympus,  model  KD-610L)  in  the  endocut
mode  was  used  to  do  the  circumference  of  the  lesion  out-
side  the  coagulation  markers.  Complete  dissection  of  the
lesion  was  performed  using  endocut  mode  (Olympus  elec-
trosurgical  unit  HF-120,  80/60  W)  with  further  submucosal
injections  as  needed  being  made  throughout  the  procedure.
CO2 insufﬂation  was  not  used  as  it  is  not  available  at  our
center.
All  procedures  were  performed  under  deep  sedation  or
general  anesthesia  (with  propofol  and  fentanyl)  supervised
by  an  anesthesiology  team.
2.3.  Deﬁnitions:  procedural  time  and  potential
predictive factors
Procedural  time  was  deﬁned  as  the  time  of  anesthesia,  in
minutes,  reported  in  patients’  clinical  ﬁles  by  the  anesthesi-
ology  team.  Thereafter,  two  groups  were  created  according
to  a  time  shorter  or  longer  than  90  min  of  procedure  given
that  the  median  time  of  all  the  procedures  was  85  min.
In  order  to  determine  the  inﬂuential  factors  on  procedure
time  the  following  variables  were  analyzed:
-  Regarding  the  lesion: Gross  cross-sectional  dimension
of  the  lesion  at  the  diagnostic  procedure  (measured
endoscopically)  in  millimeters,  followed  by  sub-grouping
in  lesions  ≤20  mm  (absolute  indication  for  endoscopic
resection  on  differentiated  lesions  without  ulcerative
ﬁndings27)  and  >20  mm,  histopathological  ﬁndings  at  diag-
nostic  biopsy  (low-grade  dysplasia,  high  grade  dysplasia
or  T1a),  location  (upper,  middle  and  lower  third  of
the  stomach),  macroscopic  type  (organized  by  Paris
classiﬁcation,28 followed  by  sub-grouping  in  depressed
and  non-depressed  lesions)  and  histopathological  deﬁni-
tive  classiﬁcation  deﬁned  by  the  presence  or  absence  of
submucosal  invasion.
- Regarding  the  patient: Age,  gender,  presence  of  co-
morbidities,  previous  suspension  of  anti-platelet  drugs
and  general  condition  of  the  patient,  evaluated  by  the
American  Society  of  Anesthesiology  score  (ASA  1,  2,  3,  4
or  5).29
-  Regarding  the  procedure:  Type  of  anesthesia  (sedation
vs  general  anesthesia);  existence  (and  type)  of  adverse
events;  adverse  events  were  deﬁned  as:  perforation  was
deﬁned  as  mesenteric  fat  or  intra-abdominal  space  visi-
ble  through  the  gastric  wall  during  the  procedure  and/or
postprocedural  clinical  and  imagiologic  signs  of  peritoni-
tis  due  to  perforation;  bleeding  was  only  considered  as
an  adverse  event  when  a  procedural  bleeding  could  not
be  managed  without  endoclips  (signiﬁcant  intraproce-
dure  bleeding)  or  required  surgery  and/or  transfusion  of
red  blood  cells  (acute  bleeding)  or  as  a  postoperative
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bleeding  with  a  decrease  of  the  hemoglobin  level  more
than  2  g/dL  and/or  need  for  blood  transfusions,  endo-
scopic  or  surgical  intervention  because  of  hematemesis
or  melena  (delayed  bleeding).
.4.  Comparison  with  previous  studies
or  the  purpose  of  comparison  with  previous  stud-
es  we  applied  the  formula  developed  by  Goto
t  al.,16 for  prediction  of  time  of  procedure:  pre-
ictive  procedural  time  (min)  = 2.384  ×  (tumor  size,
m)  +  38.568  ×  (location)  +  40.333  ×  (ulcerative  ﬁndings)
location  in  the  upper-third  of  the  stomach,  1;  the  middle
r  the  lower  third  of  the  stomach,  0;  presence  of  ulcerative
ndings,  1;  and  the  absence  of  ulcerative  ﬁndings,  0].
.5.  Statistical  analysis
tatistical  Package  for  Social  Sciences  (SPSS  21.0  Package
acility,  SPSS  Inc.,  IL,  USA)  was  used  for  data  support  and
nalysis.  Analysis  was  performed  using  descriptive  statistics
ethods,  as  well  as  Kruskal--Wallis  test  for  analysis  with  time
when  analyzed  as  a continuous  variable),  and  Chi-square
nd  Fisher’s  exact  test  for  analysis  of  dichotomic  variables
including  time  more  or  less  than  90  min  as  a  dichotomic
ariable).  Logistic  regression  was  used  to  estimate  OR  for
ndividual  variables  in  multivariate  analysis.  A value  of
 <  0.05  was  considered  to  be  statistically  signiﬁcant.  Pear-
on’s  test  was  used  for  linear  regression  correlation  analysis.
.  Results
.1.  Characteristics  of  lesions  and  procedure
f  the  127  lesions,  55%  were  performed  on  male  patients
ith  an  average  age  of  69  (±10.9)  years  old  and  a  median  of
1  (IQR  61--77).  Eight  (6%)  lesions  were  located  on  the  upper
hird,  27  (21%)  on  the  middle  third  and  92  (72%)  were  located
n  the  lower  third.  The  median  time  of  procedure  was  of
5  min  (IQR  55--130).  The  median  lesion  size  was  of  20  mm
IQR  15--30).  Globally,  93%  of  the  lesions  were  resected  en
loc  with  R0  achieved  in  91%  of  the  cases.  Adverse  events
bleeding)  occurred  in  13%  of  the  procedures.
.2.  Factors  predictive  of  ESD  procedure  time
umor  size,  location  and  the  ASA  score  were  signiﬁcantly
ssociated  with  procedure  time  (Table  1).  Speciﬁcally,  a  pro-
edure  for  a  lesion  >20  mm,  located  at  the  upper  third  of  the
tomach  and  in  a  patient  with  an  ASA  of  three  were  associ-
ted  with  longer  procedure  time,  with  results  signiﬁcantly
ifferent  from  the  other  characteristics  on  the  same  group.
ther  patients’,  lesions’  and  characteristics  of  procedure
re  shown  in  Table  1.
Procedures  were  furthermore  analyzed  in  two  different
roups  --  those  taking  less  than  and  those  taking  more  than
0  min.  These  results  are  consistent  with  the  ﬁndings  on  the
revious  analysis,  as  the  majority  of  the  cases  (72%)  with  a
esion  ≤20  mm  lasted  90  min  or  less,  while  the  majority  of
he  cases  with  a  lesion  >20  mm  (66%)  lasted  for  more  than
56  F.  Ribeiro-Mourão  et  al.
Table  1  Characteristics  of  patients,  lesions  and  procedure  with  univariate  analysis  for  predictors  of  longer  procedure  time  and
procedure time  greater  than  90  min.  p  <  0.05  was  considered  as  statistically  signiﬁcant.
Characteristics  n  Time
Median  (IQR)  p  value  <90  min  >90  min  p  value
Procedures  (total)  127  85  (55--130)
Gender 0.443
Male 70  97.5  (50--140) 34  (49%) 36  (51%)  0.065
Female 57  80  (60--120) 37  (65%) 20  (35%)
Agea 71  (61--77) 0.705
≤65  42  85  (43.75--121.25)  25  (60%)  17  (40%)  0.564
>65 85  90  (60--140)  46  (54%)  39  (46%)
ASA 0.011*
ASA  1  31  65  (40--95)  23  (74%)  8  (26%)  0.031*
ASA  2 71  90  (55--130) 38  (54%)  33  (46%)
ASA 3 25  120  (62.50--165) 10  (40%)  15  (60%)
Co-morbidities  0.125
Yes 92  90  (30--112.75)  47  (51%)  45  (49%)  0.076
No 35  72.5  (55--140)  24  (69%)  11  (31%)
Anti-platelets  0.153
Yes 25  105  (60--187.5)  12  (48%)  13  (52%)  0.374
No 102  85  (48.75--126.25)  59  (58%)  43  (42%)
Suspension  of  anti-platelets  0.764
Yes 14  117.5  (60--200)  5  (36%)  9  (64%)  0.416
No 8  102.5  (52.50--201.25)  4  (50%)  4  (50%)
Size of  lesion  <0.001
≤20 mm  74  65  (45--110)  53  (72%)  21  (28%)  <0.001
>20 mm  53  120  (80--147.5)  18  (34%)  35  (66%)
Histopathology  at  biopsy 0.521
LGD  40  75  (46.25--125)  26  (65%)  14  (35%)  0.367
HGD 57  90  (52.50--137.50) 29  (51%)  28  (49%)
Adenocarcinoma  30  90  (60--130)  16  (53%)  14  (47%)
Type of  lesion  0.891
Naive 121  85  (55--130)  68  (56%)  53  (44%)  0.542
Recidive 6  95  (29.75--156)  3  (50%)  3  (50%)
Location 0.022**
Upper  third  8  145  (115--253.75)  1  (12%)  7  (88%)  0.035**
Middle  third  27  90  (60--180)  15  (56%)  12  (44%)
Lower third  92  80  (46.25--120)  55  (60%)  37  (40%)
Macroscopic  features  0.833
Depressed  lesions  60  87.5  (60--130)  36  (60%)  24  (40%)  0.379
Non depressed  lesions  67  85  (45--140)  35  (52%)  32  (48%)
Submucosal  invasion  0.289
Yes 14  115  (72.5--135)  6  (43%)  8  (57%)  0.297
No 113  85  (52.50--130)  65  (58%)  48  (42%)
Adverse events  0.069
Yes 17  130  (50--200)  5  (29%)  12  (71%)  0.018
No 110  84  (53.75--122.75)  66  (60%)  44  (40%)
IQR, interquartile range; min, minutes; LGD, low-grade dysplasia; HGD, high-grade dysplasia.
Bold signiﬁes statistically signiﬁcant values.
* Statistically signiﬁcant for comparison between ASA1 and ASA3.
** Statistically signiﬁcant for comparison between upper third and lower third.
a Median age (IQR).
ons  57
Table  2  Multivariate  analysis  of  predictors  for  longer
procedure  time  (>90  min).  p  <  0.05  was  considered  as  statis-
tically signiﬁcant.
OR  (95%CI)
Size
≤20  mm  1
>20  mm  4.91  (2.29--10.50)  <0.001
Location
Lower third  1
Middle  third  1.182  (0.46--3.07)  0.731
Upper third 18.26 (2.02--164.78) 0.01
Adverse  events
No  1
Yes  2.84  (0.84--9.63)  0.093
ASA
1--2 1
3  1.713  (0.63--4.65)  0.292
OR, odds ratio; CI, conﬁdence interval.
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90  min  (p  <  0.001).  Also,  lesions  located  on  the  upper  third
took  more  than  90  min  (88%),  compared  to  lesions  at  other
locations  (p  <  0.035)  and  gross  majority  of  lesions  in  patients
with  ASA1  took  less  than  90  min  to  remove  (74%)  while  lesions
on  patients  with  ASA  3  took  more  than  90  min  on  60%  of
the  cases  (p  =  0.031).  Moreover,  this  analysis  also  shows  that
intra-procedure  adverse  events  pushed  the  procedure  time
to  more  than  90  min  as  71%  of  the  procedures  with  adverse
events  took  more  than  90  min  (p  =  0.018).  Characteristics
with  a  statistically  signiﬁcant  difference  at  univariate  anal-
ysis  (p  <  0.05)  were  then  computed  for  multivariate  analysis
(Table  2).  Those  patients  harboring  lesions  larger  than  20  mm
and  located  to  the  upper  third  showed  an  increased  risk
of  4.91  times  [95%CI  2.29--10.50]  and  18.26  times  [95%CI
2.02--164.78],  respectively  and  independently  with  p  <  0.05.
The  occurrence  of  adverse  events  during  the  procedure  and
the  ASA  score  do  not  seem  to  be  independently  predicting
procedural  time  longer  than  90  min.  Furthermore,  type  of
anesthesia  did  not  inﬂuence  procedure  time.
Trends  for  time  of  procedure  according  to  lesion’s  size
and  location  can  be  found  in  Fig.  2.
3.3.  Comparison  with  previous  studies
Correlation  between  the  registered  time  of  procedure  and
the  predicted  time  of  procedure  is  shown  in  Fig.  3 (Pearson’s
r  =  0.430).4. Discussion
To  the  best  of  our  knowledge  this  is  the  ﬁrst  study  relat-
ing  ESD  time  of  procedure  with  factors  from  the  lesion,
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atient  and  the  procedure  itself  in  Western  countries.  We
howed  that  lesions  with  more  than  20  mm,  located  on  the
pper  third  of  the  stomach  have  a time  of  procedure  sig-
iﬁcantly  higher  than  smaller  lesions,  on  middle  and  lower
tomach.  Co-morbidities  should  be  taken  into  account  but
nly  larger  lesions  and  lesions  on  the  upper  third  are  inde-
endent  predictors  for  longer  procedure  time.  Our  results
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ay  permit  to  establish  these  factors  relevant  for  planning
nd  management  of  these  patients.
.1.  Predictive  factors  of  prolonged  time  of
rocedure
omparing  the  different  characteristics  of  the  lesions,
 cross  sectional  dimension  >20  mm  had  longer  proce-
ure  times  when  compared  to  lesions  ≤20  mm  (120  (IQR
0--147.50)  min  vs  65  (IQR  45--110)  min,  p  <  0.001).  Moreover,
hen  the  lesion  was  located  on  the  upper  third  the  median
ime  was  of  145  (IQR  115--253.75)  min,  signiﬁcantly  differ-
nt  from  times  recorded  for  lesions  on  the  lower  third  with
 median  time  of  80  (IQR  46.25--120)  min,  p  =  0.022.  In  what
elates  to  the  general  condition  of  the  patient,  measured  by
he  ASA  score,  ASA  3  patients  had  a  median  procedure  time
f  120  (IQR  62.5--165)  min,  clearly  longer  than  patients  with
SA  1  with  a  median  time  of  65  (IQR  40--95)  min,  p  =  0.011.
e  also  showed  that  these  same  characteristics  tend  to  be
ssociated  with  a  procedure  longer  than  90  min.  In  fact,
he  size  and  location  were  independently  associated  with  a
ime  longer  than  90  min  whereas  the  risk  proﬁle  of  patients
nd/or  the  evidence  of  adverse  events  (bleeding)  during  the
rocedures  were  not  independent.
The  reasons  why  the  ﬁrst  two  factors  can  act  as  predic-
ors  for  a  longer  time  of  procedure  can  be  easily  explained  --
 larger  lesion  will  obviously  require  a  higher  area  to  be  diss-
cted  and  therefore  more  time;  the  location  at  the  upper
hird,  due  to  the  position  required  for  the  scope  and  the
all  characteristics,  require  more  technical  skills.7,30,31 Nev-
rtheless,  for  the  other  two  factors  we  may  have  different
easons  not  to  observe  them  as  independent  predictive  fac-
ors  --  bleeding  is  expected  more  often  in  lesions  in  the  upper
hird32 and  ASA  3  patients  prevalence  is  very  low  and  they
t
c
id  the  predicted  time  of  procedure  by  Goto  et  al.  formula.
end  to  be  older  [median  age  of  75  (IQR  69.5--80)  vs  70  (IQR
9--76)  on  ASA  1  and  2,  p  =  0.005]  what  may  lead  to  larger
median  dimension  of  30  mm  (IQR  18--30)  on  ASA  3  vs  20  mm
IQR  15--25)  on  ASA  1  and  2,  p  =  0.037]  and  more  advanced
esions.
.2.  Predictive  factors  compared  to  eastern  series
oreover,  the  majority  of  our  ﬁndings  are  in  accordance
ith  previous  ﬁndings  in  eastern  series,  speciﬁcally  in  what
egards  to  size  and  location  of  lesion.7,15--19
Goto  et  al,16 developed  a  formula  to  predict  the  time
f  procedure  based  on  size  of  lesion,  location  on  the  upper
hird  and  presence  of  ulceration.  Comparing  to  our  results,
nd  considering  the  non-existence  of  ulcerated  lesions  on
his  series,  for  a  lesion  of  20  mm  or  more  and  located  on
he  upper  third,  its  predicted  time  of  procedure  is  never
ess  than  86  min  which  is  in  accordance  with  our  ﬁndings
hat  those  two  factors  are  associated  with  a  procedure  time
onger  than  90  min.  The  correlation  between  the  registered
ime  of  procedure  and  the  predicted  time  of  procedure  on
his  formula  is  shown  in  Fig.  3  (Pearson’s  r  =  0.430).
Our  results  are  also  consistent  with  previous  ﬁndings  by
hn  et  al,18 as  the  predicted  times  of  procedure  for  lesions
n  the  upper  third  with  more  than  30  mm  are  always  superior
o  90  min.  However,  it  does  not  have  the  same  conclusion  to
esions  between  21  and  30  mm.
Regarding  the  intra-procedure  adverse  events  predicting
 longer  time  of  procedure  (>90  min)  it  is  in  agreement  with
revious  ﬁndings  by  Yamamoto  et  al,33 stating  that  uncon-
rolled  hemorrhagic  makes  the  procedure  lengthier.
We  have  also  linked  a  higher  ASA  score  to  a  prolonged  pro-
edure  time.  However,  this  ﬁnding  contradicts  Kim  et  al.,34
f  we  assume  that  a  ASA  3  is  similar  to  their’s  high  risk  group
ons  
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deﬁned  as  having  one  or  more  co-morbidity  states.  How-
ever,  it  is  not  clear  if  this  contradiction  is  real  or  if  it  is
due  to  different  classiﬁcation  systems  and  it  was  not  con-
ﬁrmed  as  an  independent  factor.  Interestingly  we  did  not
ﬁnd  that  any  medication,  including  anticoagulants,  interfere
with  procedure  time.
4.3.  Limitations
One  of  the  limitations  of  our  study  has  to  do  with  the
standard  used  to  calculate  time  of  procedure,  based  on  the
time  of  anesthesia.  This  means  that  our  times  of  procedure
can  be  slightly  superior  to  the  ones  found  on  other  stud-
ies  that,  for  instance,  count  the  time  only  on  the  beginning
of  lesion’s  marking  and  that  the  procedure  chosen  for  the
anesthesia  can  also  have  a  different  impact  on  the  global
time  itself.  Nevertheless,  the  mean  time  of  procedure  on
this  series  is  similar  to  times  reported  on  different  eastern
series  and  for  purposes  of  human  resources  and  room  allo-
cation  it  is  interesting  to  consider  the  time  of  anesthesia  as
a  time  of  procedure  as  it  is  more  accurate.
However,  it  can  have  an  impact  on  the  ﬁnding  of  the  rela-
tion  with  the  ASA  score,  as  this  one  could  relate  directly  to
time  of  anesthesia  and  not  with  time  of  procedure.  Also,  it
has  also  been  reported  on  literature  that  many  times  the  ASA
score  is  subjective  to  inter-observer  variations.35 Therefore,
this  ﬁnding  should  be  looked  with  special  attention.
However,  future  studies  should  focus  on  the  analysis  of
time  of  anesthesia  and  time  of  procedure  itself  alone,  eval-
uated  at  the  same  time,  to  give  us  a  perspective  on  the
impact  of  adverse  events  of  the  procedure  itself  or  anes-
thesic  adverse  events  on  the  global  time.
Another  limitation  has  to  do  with  the  evaluation  of  size
being  done  with  a  cut-off  point  in  the  20  mm,  a  method-
ological  option  that  has  to  do  with  the  size  of  our  series  not
allowing  comparisons  in  smaller  groups.
A  different  limitation  has  to  do  with  the  fact  that  we  only
considered  IT-knife  for  analysis  for  the  scope  of  this  study  as
previous  studies  refer  that  different  knives  have  different
times  of  procedure  associated.36 However,  the  option  here
was  purely  methodological  as  we  had  cases  on  our  series  with
other  knives,  but  the  choice  of  other  knives  or  concomitant
knives  with  IT-knife  was  based  on  the  fact  that  lesions  were
identiﬁed  as  more  complicated  and  lengthy,  that  made  us  to
opt  to  focus  on  only  one  knife,  so  this  bias  was  not  present
on  this  study.  Anyway,  further  studies  comparing  times  of
procedure  with  different  knives  can  be  an  interesting  area
for  research.
Finally,  we  do  not  have  consistently  recorded  data  for
ﬁbrosis  and  existence  of  scar  throughout  the  observation
period,  bringing  to  the  surface  the  limitation  of  this  study
being  a  retrospective  study  and  subsequently  the  com-
parisons  with  other  works.  The  deﬁnition  of  long-term
prospective  studies  on  this  area  with  the  focus  on  study-
ing  factors  inﬂuencing  time  of  procedure  are  the  key  for
obtaining  consistent  and  comparable  data  worldwide.5. Conclusion
In  summary,  we  found  that  lesions  on  the  upper  stom-
ach,  greater  than  20  mm  and  in  patients  with  signiﬁcant
159
o-morbidities  can  increase  the  time  of  procedure  and  it
s  expected  that  it  will  last  more  than  90  min,  with  the  ﬁrst
wo  being  independent  predictors.  It  is  important  to  keep  in
ind  if  these  three  factors  are  present  on  a  certain  lesion
efore  the  procedure,  so  an  adequate  planning  of  operation,
uman  resources  and  anesthetic  method  can  be  performed,
herefore  allowing  an  increased  efﬁcacy  and  efﬁciency.
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